The success of Viagra initially fueled a period of growth for pharma, however recent developments present a murky picture for investors. Lower-cost alternatives are eating into earnings, and persistent litigation add https://jasongunv724382.tkzblog.com/40941508/sildenafil-and-pharma-a-volatile-bet